These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29915614)

  • 1. Use of rotational atherectomy for reducing significant dissection in treating de novo femoropopliteal steno-occlusive disease after balloon angioplasty.
    Kim TH; Katsetos M; Dahal K; Azrin M; Lee J
    J Geriatr Cardiol; 2018 Apr; 15(4):254-260. PubMed ID: 29915614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
    Engin AY; Saydam O
    Vascular; 2021 Oct; 29(5):682-692. PubMed ID: 33167805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Wu Z; Huang Q; Pu H; Qin J; Wang X; Ye K; Lu X
    Eur J Vasc Endovasc Surg; 2021 Jul; 62(1):65-73. PubMed ID: 34112574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
    Stavroulakis K; Bisdas T; Torsello G; Argyriou A; Bollenberg L; Schwindt A
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty of Chronic Femoropopliteal Occlusions.
    Tan M; Urasawa K; Koshida R; Haraguchi T; Kitani S; Igarashi Y; Sato K
    J Endovasc Ther; 2018 Apr; 25(2):192-200. PubMed ID: 29429382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
    Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
    J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Atherectomy Combined With Balloon Angioplasty vs Balloon Angioplasty Alone in Patients With Femoro-Popliteal Lesions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pan D; Guo J; Su Z; Meng W; Wang J; Guo J; Gu Y
    J Endovasc Ther; 2023 Dec; ():15266028231215354. PubMed ID: 38049942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).
    Ott I; Cassese S; Groha P; Steppich B; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Hiendlmayer R; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    Circulation; 2017 Jun; 135(23):2218-2226. PubMed ID: 28424222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Specific Analysis of Mid-Term Outcomes of Atherectomy-Assisted Endovascular Treatment in Severe Peripheral Arterial Disease.
    Avranas K; Pitoulias AG; Taneva GT; Beropoulis E; Donas KP
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892949
    [No Abstract]   [Full Text] [Related]  

  • 11. Technical performance and reproducibility following rotational atherectomy of femoropopliteal artery occlusive lesions: analysis of the multicenter MORPHEAS Registry.
    Donas KP; Taneva GT; Pitoulias GA; Jomha A; Schröder M; Psyllas A; Scali S; Abu Bakr N;
    J Cardiovasc Surg (Torino); 2022 Feb; 63(1):13-19. PubMed ID: 35179338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of chronic obstructive femoropopliteal arterial disease.
    Liu H; Gu Y; Yang S; He J; Zhang F
    Exp Ther Med; 2020 Mar; 19(3):1887-1895. PubMed ID: 32104245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
    Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
    Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 17. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries.
    Giannopoulos S; Strobel A; Rudofker E; Kovach C; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2021 Aug; 28(4):593-603. PubMed ID: 34002659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z; Guo L; Qi L; Cui S; Tong Z; Guo J; Wang Z; Gu Y
    Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.